IRIS
Gennari, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.988
NA - Nord America 3.140
AS - Asia 2.633
SA - Sud America 532
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 10.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.033
IE - Irlanda 1.038
IT - Italia 956
SG - Singapore 833
DE - Germania 558
HK - Hong Kong 514
CN - Cina 454
BR - Brasile 398
VN - Vietnam 380
SE - Svezia 377
UA - Ucraina 325
RU - Federazione Russa 322
GB - Regno Unito 115
ID - Indonesia 94
IN - India 93
KR - Corea 81
FR - Francia 75
CA - Canada 62
BJ - Benin 58
AR - Argentina 52
FI - Finlandia 51
AT - Austria 43
BD - Bangladesh 34
MX - Messico 30
IR - Iran 26
NL - Olanda 26
TR - Turchia 24
PL - Polonia 23
JP - Giappone 19
LT - Lituania 19
PK - Pakistan 19
EC - Ecuador 18
ES - Italia 18
BE - Belgio 16
IQ - Iraq 16
ZA - Sudafrica 16
PY - Paraguay 14
VE - Venezuela 13
PE - Perù 12
CO - Colombia 10
MA - Marocco 9
CL - Cile 8
EU - Europa 8
UZ - Uzbekistan 8
DZ - Algeria 7
AU - Australia 6
CZ - Repubblica Ceca 6
EG - Egitto 6
KE - Kenya 5
NP - Nepal 5
BO - Bolivia 4
ET - Etiopia 4
KG - Kirghizistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
MK - Macedonia 3
PH - Filippine 3
RO - Romania 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
RS - Serbia 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CU - Cuba 1
DM - Dominica 1
GD - Grenada 1
GT - Guatemala 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 10.420
Salva come PNG Salva come JPEG
Città #
Dublin 1.032
Jacksonville 597
Hong Kong 513
Piemonte 373
Singapore 366
Ashburn 261
Beijing 239
Dearborn 230
Moscow 135
Lawrence 129
Princeton 129
Wilmington 126
Los Angeles 124
Dong Ket 116
Ho Chi Minh City 106
Chandler 96
Seoul 77
Jakarta 75
Buffalo 71
Novara 63
Cotonou 58
Bremen 47
Redondo Beach 47
Ann Arbor 46
New York 46
Nuremberg 44
San Mateo 44
Hanoi 43
Munich 43
São Paulo 42
Milan 40
Helsinki 38
Dallas 36
Santa Clara 30
Toronto 29
Turin 24
Falkenstein 21
Houston 21
London 21
Boardman 20
Frankfurt am Main 20
Orem 20
Rome 19
Vienna 19
Denver 18
Warsaw 18
Tokyo 17
Brussels 16
Montreal 16
Poplar 16
Chennai 15
Tianjin 15
Nanjing 14
Phoenix 14
Amsterdam 13
Andover 13
Biên Hòa 13
Brooklyn 13
Mexico City 13
Norwalk 13
Rio de Janeiro 13
Strasbourg 13
Turku 13
Atlanta 12
Johannesburg 12
Monmouth Junction 12
Ankara 11
Haiphong 11
Boston 10
Fairfield 10
Hefei 10
Kunming 10
Reggio Emilia 10
Stockholm 10
Da Nang 9
Guangzhou 9
Naples 9
Odalengo Grande 9
San Francisco 9
Zanjan 9
Ardabil 8
Baghdad 8
Brasília 8
Grafing 8
Lima 8
North Ridgeville 8
Seattle 8
Thái Bình 8
Asunción 7
Chicago 7
Genoa 7
Ninh Bình 7
Paris 7
Querétaro 7
Quito 7
Redwood City 7
Tashkent 7
Alessandria 6
Assago 6
Buenos Aires 6
Totale 6.269
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 206
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 179
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 152
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 139
Insulin-like Growth Factor-1 Receptor (IGF-1R) expression on Circulating Tumor Cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial 122
A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial 113
Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer 112
Bone health, vitamin D status and oral hygiene screening in breast cancer women before starting osteoporosis treatment: a cross-sectional study 109
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study 108
Metastatic mediastinal germ-cell tumor and concurrent COVID-19: when chemotherapy is not deferrable. 106
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study 105
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 101
Aging and endothelial function in normotensive subjects and patients with essential hypertension 99
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 98
Anthracyclines in the management of metastatic breast cancer: state of the art 96
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 96
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 96
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 95
Curative Lung Metastasectomy Without Concomitant Androgen Deprivation Therapy in Oligometastatic Castration-resistant Prostate Cancer: A Case Report and Review of the Literature 94
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab 93
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 92
A Simon's two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities 91
Breast Cancer Survivorship, Quality of Life and Late Toxicities 90
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 90
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma] 89
ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution 89
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 89
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 85
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer 85
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 85
Oncolytic virotherapy: new weapon for breast cancer treatment 84
Adjuvant chemotherapy in breast cancer. International perspective 83
Anthracycline-free therapy for HER2-amplified breast cancer 82
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT 82
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer 81
Identification of a prognostic signature based on the expression of genes related to the insulin pathway in early breast cancer 81
Age influence on some aspects of cardiovascular adaptation to hypertension 80
Dual block with lapatinib and trastuzumab versus single agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials 79
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. 78
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 77
Anthracyclines-paclitaxel combinations in the treatment of breast cancer 76
Gestione di nausea e vomito nel paziente oncologico. Utilizzo di cerotti transdermici contenenti granisetron in paziente affetto da neoplasia del distretto cervico-cefalico 76
Precision Medicine in Systemic Mastocytosis 76
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer 75
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial 74
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 74
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer 72
Bevacizumab and breast cancer: A meta-analysis of first-line phase III studies and a critical reappraisal of available evidence 72
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial 72
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review 71
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: A regimen with high activity and low cardiotoxicity in advanced breast cancer 70
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey 70
Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study 69
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 69
Cardiotossicità da antracicline 69
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. 68
New combinations with epirubicin in advanced breast cancer 67
Extending the duration of first-line chemotherapy in metastatic breast cancer: A perspective review 67
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 67
[18F]FDG-PET/CT in adrenal lesions: diagnostic performance in different clinical settings 67
Survival of metastatic breast carcinoma patients over a 20-year period - A retrospective analysis based on individual patient data from six consecutive studies 66
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer 66
Apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC) 66
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy 64
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression. 64
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 64
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 63
New Understanding of the Role of Anthracyclines in Early-Stage Breast Cancer: Patient Selection Considerations 63
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 63
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors 62
The quality of life issue in metastatic breast cancer 62
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 62
Impact of Body Mass Index (BMI) on the prognosis of high risk early breast cancer (EBC) patients treated with adjuvant chemotherapy 62
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast Cancer 62
Precision Medicine Approaches with Metabolomics and Artificial Intelligence 61
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 61
Paclitaxel plus epirubicin in advanced breast cancer 61
Microinjections of alpha 1- and alpha 2-noradrenergic substances in the cerebellar vermis of decerebrate cats affect the gain of the vestibulospinal reflexes 60
Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study 60
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 59
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer 59
Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel 59
Breast Cancer Diet "BCD": A Review of Healthy Dietary Patterns to Prevent Breast Cancer Recurrence and Reduce Mortality 59
Stereotactic ablative radiotherapy for oligometastatic prostate cancer 57
Cancer and fertility preservation: international recommendations from an expert meeting 57
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 57
Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study 56
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial 56
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia 56
Pemetrexed: A promising new treatment for breast cancer 56
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer 56
Why are guidelines not followed in clinical practice? 55
Identification and validation of a new set of five genes for prediction of risk in early breast cancer 55
Case histories: breast cancer 54
Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients 54
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice 54
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 54
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer 53
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer 53
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 52
Totale 7.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021589 0 0 0 0 0 34 136 16 130 19 122 132
2021/2022892 65 23 84 107 29 33 60 32 92 60 135 172
2022/20231.814 162 69 132 18 69 138 54 75 992 21 45 39
2023/2024756 90 29 53 26 128 17 126 17 19 13 52 186
2024/20252.045 28 26 140 31 53 138 255 214 607 193 76 284
2025/20262.803 294 238 458 895 623 295 0 0 0 0 0 0
Totale 10.789